News

Tandem Diabetes and Eli Lilly Collaborate on Insulin Pump Tech

Tandem Diabetes and Eli Lilly Collaborate on Insulin Pump Tech

Tandem Diabetes Care Partners with Eli Lilly for New Technology

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), known for its innovation in insulin delivery systems, recently announced an exciting development. Their t:slim X2 insulin pump is now approved for use with Eli Lilly and Company’s Lyumjev ultra-rapid acting insulin in the United States. This marks a significant advancement in the tools available for managing diabetes.

Enhancing Diabetes Management with Smart Technology

Jordan Pinsker, MD, Chief Medical Officer at Tandem, highlighted this progression, stating, "This latest milestone reinforces our commitment to facilitating choice and access for people who rely on insulin therapy." This enhancement allows individuals aged two and above with type 1 diabetes, as well as adults with type 2 diabetes, to use Lyumjev in conjunction with the t:slim X2 pump. The flexibility offered here is a vital improvement for those managing diabetes.

Groundbreaking Study Results Support the Clearance

The approval for use of Lyumjev with the t:slim X2 was based on compelling data obtained from a 13-week multicenter study involving 179 participants. This research demonstrated high satisfaction levels and notable quality of life improvements among users. Although Lyumjev received general approval for use in insulin pumps in 2021, individual pump manufacturers had to validate compatibility through thorough testing.

Collaboration Between Tandem and Eli Lilly

Tandem and Lilly have diligently worked together to support this clinical trial, which corroborated the benefits of utilizing Lyumjev alongside Control-IQ+ technology. Furthermore, the companies are focused on securing compatibility for the Tandem Mobi pump with Lyumjev, further expanding options for patients.

Access and Support Through Lilly’s Insulin Value Program

Lyumjev is accessible to a large number of patients through the Lilly Insulin Value Program, which allows individuals with commercial insurance, as well as those without coverage, to fill a monthly prescription for just $35. This affordability initiative exemplifies a commitment to making necessary treatments accessible.

Broader Applicability of the t:slim X2 Pump

The t:slim X2 insulin pump has also been approved for use with other insulin types, including Humalog and Novolog, broadening the spectrum of choices available to users. This approval significantly enhances the versatility of the pump and its ability to cater to various patient needs.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care is committed to revolutionizing the management of diabetes through its cutting-edge insulin delivery systems. Their offerings include advanced technologies, such as the Tandem Mobi system and the t:slim X2 insulin pump, both of which incorporate the state-of-the-art Control-IQ+ technology. Based out of San Diego, the company focuses on reducing the strain of diabetes management for patients, healthcare providers, and families.

Connect With Tandem Diabetes Care

To stay updated about Tandem Diabetes Care, you can follow them on TikTok, and their various social media platforms, including Facebook, Instagram, LinkedIn, and X.

Frequently Asked Questions

What is the significance of the t:slim X2 insulin pump?

The t:slim X2 insulin pump is significant because it offers advanced features that help individuals manage their diabetes more effectively, including compatibility with innovative insulins like Lyumjev.

How does Control-IQ+ technology benefit users?

Control-IQ+ technology automatically adjusts insulin delivery based on glucose readings, helping to stabilize blood sugar levels and reduce the burden of diabetes management.

Who can use the t:slim X2 pump with Lyumjev?

Individuals aged two and older with type 1 diabetes, as well as adults with type 2 diabetes, can use the t:slim X2 pump with Lyumjev for insulin delivery.

How does the Lilly Insulin Value Program work?

The Lilly Insulin Value Program allows eligible individuals with or without insurance to obtain a monthly prescription of Lyumjev for only $35, making it more accessible.

What other insulins are compatible with the t:slim X2 pump?

In addition to Lyumjev, the t:slim X2 insulin pump is also approved for use with Humalog and Novolog insulin types, offering users more treatment options.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Odessa Water Overbilling Lawsuit Surges Ahead

Updated Category News Views 181

Full Steam Ahead for Odessa's Water Fight Odessa, a dust-blown Texas town, ain't giving up without a fight. The court just lit a fire under the efforts of 46,000 residents and businesses hollering about their water bills that seemed to skyrocket outta nowhere. This court ruling lets the class action against the City of Odessa and Performance Services—they're the folks...

Continue Reading
AI Deception Challenges the Confidence of Fraud Defenses

Updated Category News Views 120

Fraud Week Spotlights AI Deception Alright, here's the rub: we're in Fraud Week 2026, and boy, is AI shaking the foundations of yesterday's fraud defenses! With all this AI talk, you would expect systems to be near invincible by now. But reality? A different beast altogether. AI has this knack of tripling up the complexity while pretending to solve it, making traditional...

Continue Reading
Choosing the Right Pressure-Treated Lumber for Projects

Updated Category News Views 115

Diving into the World of Pressure-Treated Lumber John Michael Nixa, the go-to expert from West Side Lumber, has dropped some real nuggets in the world of pressure-treated lumber. This isn't some clickbait headline; it's about making sure your deck or fence doesn't fall apart after the first thunderstorm. Understanding the Lumber Treatment Now, before you run off to the...

Continue Reading
Noël Jolié's Cream Earns Spot on Oprah's List

Updated Category News Views 98

The Powerhouse of Oprah's Seal of Approval Ever notice what happens when Oprah drops a nod towards any brand? It's like Midas touching everything gold. That's exactly the scenario with Noël Jolié, a Chicago-based luxury body care operation, hitting the jackpot by landing its Velours Silken Body Cream on Oprah's Favorite Things 2026. You can't buy this kind of press,...

Continue Reading
D-Wave's 9.5% Drop: Fraud Lawsuit Raises Investor Ire

Updated Category News Views 59

Shockwaves from D-Wave's Earnings Call August wasn't exactly a banner month for D-Wave Quantum, Inc. as their stock went down like a lead balloon following a lackluster earnings report. If you've ever had any skin in the game, you'd know a 9.5% drop isn't just peanuts—it's the equivalent of watching your prized racehorse stumble at the first hurdle. The financials spoke...

Continue Reading
Bybit Expands ByPick Game with Broader Market Reach

Updated Category News Views 124

Bybit Plays the Game of Expansion Step right up to Bybit’s latest offering – ByPick Season 2. Some folks might be scratching their heads about what's shifting in this free-to-play space, but here we are, watching a beast that’s a mix between a carnival game and a hedge fund playpen. No money exchanged, just knowledge on the line. That's right, we're diving into a...

Continue Reading
NVIDIA Faces Legal Turbulence: CEO's Exit Sparks Chaos

Updated Category News Views 98

Jensen Huang's Sudden Exit: A Barrage of Headlines In what feels like a blow delivered by a sledgehammer, NVIDIA is rocked by the abrupt resignation of its iconic co-founder and CEO, Jensen Huang. This isn't some quiet departure into the night. Nope, it's more like a cannonball being fired into the investor lounge, leaving a wreckage for all to navigate through. Huang's...

Continue Reading
Balancing Rigor and Interests in Education: Insights

Updated Category News Views 135

Education: A Balancing Act of Academics and Interests So here's the deal, folks. Education isn't just about hitting the textbooks and acing exams. It's a wild dance—balancing rigorous academics and the extracurricular hustle. Brent Reckman, the brains behind The Academy of Charter Schools in Westminster, Colorado, knows this orchestra well. In a feature with...

Continue Reading
Optikos Secures CMMC Level 2, Eyeing Defense Market

Updated Category News Views 92

Optikos Levels Up with CMMC Certification In a world where cybersecurity threats are lurking around every corner, Optikos has just joined the rarefied ranks of the top 1% of U.S. defense suppliers by grabbing the CMMC Level 2 certification. Let me tell you, this isn't just some shiny badge for show; it's a gateway to big defense contracts. Crunching the Numbers Of the...

Continue Reading
HNTB Partners with Kansas City Chiefs for New Stadium

Updated Category News Views 94

A New Chapter for the Kansas City Chiefs Are we witnessing the dawn of a new era for the Kansas City Chiefs? Officially naming HNTB as the architect for their upcoming stadium signals a strategic pivot, aimed at not just snagging eyeballs, but embedding Kansas City deeper into the sports architecture hall of fame. Unveiled during the Power Brokers Sports-Anchored...

Continue Reading

Top 5 Most Recently Viewed Articles

IMF Delegates Argentina Negotiations Amid Rising Tensions

Updated Category News Views 196

Understanding the Recent Developments in IMF Talks with Argentina The International Monetary Fund (IMF) is currently navigating a complicated landscape in its negotiations with Argentina, showcasing the ever-evolving nature of international finance and politics. Recently, Rodrigo Valdes, the IMF director for the Western Hemisphere, has officially assigned all negotiation...

Continue Reading
IO Biotech Showcases Innovative Cancer Treatments Through Vaccines

Updated Category News Views 194

IO Biotech Unveils Breakthrough Pre-Clinical Data for Cancer Vaccines IO Biotech, a clinical-stage biopharmaceutical company listed on the Nasdaq under the ticker IOBT, is at the forefront of developing immune-modulatory, off-the-shelf therapeutic cancer vaccines. Recently, the company revealed exciting data highlighting its two promising candidates: IO112 and IO170, both...

Continue Reading
Market Performance of Marijuana Stocks This October

Updated Category News Views 69

October Marijuana Stock Performance Overview The marijuana stock market has shown a diverse range of movements this October. Investors and enthusiasts remain eager to analyze these trends as companies navigate the ever-changing landscape of the cannabis industry. This article provides insights into the key movers within this sector, identifying both the top performers and...

Continue Reading
EQS Group Unveils 'Q': AI-Driven Compliance Revolution

Updated Category News Views 216

Compliance in the Fast Lane The compliance world just got a hefty upgrade with EQS Group's latest rollout: 'Q by EQS,' an AI-powered intelligence layer that's here to shake up the way compliance tasks are handled. It's integrated right into the heart of the EQS Compliance Cockpit, giving teams an edge by automating those pesky, time-sucking routines and guiding them...

Continue Reading
Olema Oncology Showcases Innovations at J.P. Morgan Healthcare Expo

Updated Category News Views 306

Olema Oncology to Present at Major Healthcare Event Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a dynamic clinical-stage biopharmaceutical company focused on developing targeted therapies for breast cancer and related conditions, is all set to present its innovative findings at the renowned J.P. Morgan Healthcare Conference. This key...

Continue Reading